RGNX
Regenxbio Inc
Price:  
9.06 
USD
Volume:  
476,252.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RGNX Relative Valuation

-1142.7%
Upside

As of 2025-07-11, the Relative Valuation of Regenxbio Inc (RGNX) is (94.47) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.06 USD, the upside of Regenxbio Inc based on Relative Valuation is -1142.7%.

The range of the Relative Valuation is (79.66) - (95.19) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 21.7x - 30.3x 27.2x
Forward P/E multiples 25.3x - 42.7x 32.9x
Fair Price (79.66) - (95.19) (94.47)
Upside -979.3% - -1150.7% -1142.7%
9.06 USD
Stock Price
(94.47) USD
Fair Price

RGNX Relative Valuation - Historical P/E Data

Date P/E
2025-07-03 -2.78
2025-07-02 -2.74
2025-07-01 -2.62
2025-06-30 -2.61
2025-06-27 -2.67
2025-06-26 -2.78
2025-06-25 -2.72
2025-06-24 -2.72
2025-06-23 -2.50
2025-06-20 -2.68
2025-06-18 -2.73
2025-06-17 -2.75
2025-06-16 -2.91
2025-06-13 -2.95
2025-06-12 -3.24
2025-06-11 -3.24
2025-06-10 -3.12
2025-06-09 -3.03
2025-06-06 -3.06
2025-06-05 -2.66
2025-06-04 -3.21
2025-06-03 -3.22
2025-06-02 -3.29
2025-05-30 -2.82
2025-05-29 -2.85
2025-05-28 -2.72
2025-05-27 -2.89
2025-05-23 -3.09
2025-05-22 -3.14
2025-05-21 -3.07
2025-05-20 -3.18
2025-05-19 -3.11
2025-05-16 -2.83
2025-05-15 -2.75
2025-05-14 -2.65
2025-05-13 -2.60
2025-05-12 -2.54
2025-05-09 -2.39
2025-05-08 -2.27
2025-05-07 -2.30
2025-05-06 -2.52
2025-05-05 -3.10
2025-05-02 -3.31
2025-05-01 -3.13
2025-04-30 -3.06
2025-04-29 -2.99
2025-04-28 -2.90
2025-04-25 -2.91
2025-04-24 -2.93
2025-04-23 -2.82